Interface
Adjust the interface to make it easier to use for different conditions.
Interface Size
Smaller Decrease text size
Larger Increase text size
Reset Reset text size
This renders the document in high contrast mode.
This renders the document as white on black

Vaccine

Development of COVID-19 vaccine: the Bio-Manguinhos initiative

Situational strategic planning of the pharmacovigilance of Covid-19 vaccine (ChAdOx1-S [recombinant]) at Bio-Manguinhos/Fiocruz

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial

Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study

Comparative sequence analysis of the P-, M- and L-coding region of the measles virus CAM-70 live attenuated vaccine strain

Studies on yellow fever vaccine. I. quality-control parameters

Perceptions of Human Tuberculosis Vaccine: The Fiocruz Latest Contribution

First International Workshop on Zika Virus Held by Oswaldo Cruz Foundation FIOCRUZ in Northeast Brazil March 2016: a meeting report